skip to content

Emmaus Life Sciences Issues Statement in Response to Announcement by AFH Holding & Advisory

January 25, 2013

TORRANCE, Calif., January 25, 2013 – Emmaus Life Sciences, Inc., a company dedicated to the discovery, development and commercialization of innovative and cost effective treatments and therapies for rare diseases, today issued the following statement in response to an announcement issued January 24, 2013 by AFH Holding & Advisory, LLC.